Page 2 - Astralbio Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

iBio surged after collaborating with AstralBio Inc. to develop antibodies for obesity & cardiometabolic conditions. Shares soared over 100%, hitting $2.44. Collaboration aims to target TGFb superfamily for muscle wasting & obesity treatment.

Bio incMartin brennerAstralbio incIkarian capitalInvestigational new drugChief scientific officer